Bioelectronic Medicine Company Panaxium SAS Hiring Multidisciplinary Team of Scientists and Engineers to Commercialize Bioelectronic Medicine Treatments

New hires will join world-renowned researchers leading groundbreaking development of bioelectronics materials and novel electronic devices to treat chronic disease.

Aix-en-Provence, FRANCE, and Toronto, CANADA, June 5, 2018. Bioelectronic medicine company Panaxium SAS today announced an aggressive hiring push to complete the team that will lead efforts in the commercialization of revolutionary bioelectronic medicine treatments.

The roles the company is currently looking to fill include: Bio Mechanical / Bio Medical Test Engineer, Analog Electronics Test Engineer, Process Engineer: Development / Industrialization Microfabrication, and Senior Electronics Design Engineer – Electrophysiology.

Details of job descriptions can be found on the company’s website.

Bioelectronic medicine is an emerging scientific field that aims to tackle many debilitating and degenerative medical conditions and injuries by leveraging the newest bioelectronics and building imperceptible devices at the microscale dimensions of individual cells. There is significant potential to treat a wide range of diseases such as Traumatic Brain Injuries, Parkinson’s, Alzheimer’s, and even peripheral nerve damage.

“Everyone who has joined our team has been carefully selected to join our extraordinary group of internationally-renowned scientists,” says Carolyn Aubry, Director, Operations for Panaxium. “They are leaders in fields ranging from organic bioelectronics to chemistry, materials science, electrical engineering, systems design, electronic engineering, data science, biology, microtechnology, as well as business executives with years of experience at Fortune-500 firms. Successful candidates will be inspired and motivated by the excellence of our team, and their ambition, creativity, precision, and desire for improving lives. And, above all else, they will share our audacity to believe we can continuously challenge and improve the science of healing. As we always say, ‘untreatable disease is not in our vocabulary.’ We want great thinkers, we want people who want to be bold, speak their mind, and change the future of medicine.”

Dr. Brad Schmidt, CEO of Panaxium, echoes this sentiment. “Bioelectronic medicine has the potential of being able to tell millions – millions of people around the world – that they now have a chance.  If there is anything we can do to drive this forward, we will do it. It is our company’s singular focus and dedicated passion to provide these innovations to physicians for the benefit of patients.”

A full listing of current job opportunities can be found here. For further information, please contact careers@panaxium.com.

ABOUT PANAXIUM
Founded in 2016, Panaxium is a new and rapidly-growing bioelectronic medicine company aiming to fundamentally change the way disease is treated. The company is comprised of a multidisciplinary team of internationally-renowned scientists, including world experts in organic bioelectronics and leaders in the fields of chemistry, materials science, electrical engineering, systems design, electronic engineering, data science, biology, biochemistry, and nanotechnology. Together they are working to solve some of the most difficult and important problems in medicine.


For more information about the company please visit www.panaxium.com

Back